Osteoporosis drugs-Resorption inhibitors Flashcards
Resoprtion blocking Drugs useful in treatment of Osteoporosis
Bisphosphonates “-Dronate” suffix
Pamidronate
Alendronate
Zoledronate
(“DONATion box”)
Raloxifene
(entrance lady holding “Relax” sign)
Calcitonin
(“Curator toning it down”)
Denosumab
(“Dino suit man grabbing crank drill”)
Bisphosphonates **MOA
Pamidronate
Alendronate
Zoledronate**
-bisphosphonates attach to hydroxyapatite in the bone
(“Large T-Rex appetite”)
-osteoclasts bind to the bisphosphonate, inhibiting their adherence to the bony surface
(“Classmate stuck in donation box”)
-bisphosphonates decrease the development and recruitment of osteoclast precursors
(“Preventing osteo-Class waiting to enter from entering”)
-bisphosphonates induce osteoclast apoptosis
(“Classmates popping balloon”)
Bisphosphonates can treat …
-bisphosphonates are useful in the acute treatment of hypercalemia
(“Elevated calci-yum ice cream”)
-
hypercalcemia of malignancy is a common cause of _severe hypercalcemi_a requiring acute treatment with bisphosphonates and
calcitonin
(“Massive calcified rock with metastatic crab fossils “)
——————————————————————————–
-Bisphosphonates and calcitonin are useful in the management of pagets disease
(“Disorganized bone homo paget display”)
- uncontrolled osteoclast resorption with secondary disorganized bone formation
Bisphosphonates Side Effects
- can cause upper GI side effect
- acid reflux, esophagitis, esophageal ulcers sit upright 30 min and drink water to treat
- bisphosphonates can cause osteonecrosis of the jaw
(“Crumbling jaw bone”)
-bisphosphonates can cause hypocalcemia
(“Falling calci-yum ice cream”)
(“Corroded neck of dinosaur”)
postmenopausal osteoporosis can be treated and prevented with …
Estrogen therapy
- estrogen therapy will inhibit osteoclast and osteoclast precursors differentiation
(“pre historic Female guarding class entrance”)
(“Female symbol”)
Estrogen therapy is NOT recommended because ..
-due to increased risk of breast cancer and other side effects
since Estrogen therapy is NOT recommended as a treatment of postmenopausal Osteoporosis , what other drug can be Administered to treat this condition? and why ?
Raloxifene since its an estorgen agonist in bone and estrogen antagonist in Breast and Uterus , it can treat postmenopausal osteoporosis while not increasing the risk for breast or uterine cancer seen with estrogen therapy.
Raloxifene MOA
(lady at entrance holding sign “RELAX”)
SERM - Selective Estrogen Receptor Modulator
(“Relaxing the waiting classmates”)
- has estrogen agonist activity in bone
- inhibits osteoclast differentiation
- and estrogen antagonist activity in breast and uterus
- reduced risk of breast cancer
Denosumab MOA
(“Dino suit Man”)
- PTH stimulates osteoBLASTS to express RANKL which then binds RANK on osteoCLASTS and activated them
- Denosumab is a monoclonal Antibody against RANKL
(“Dino suit man grabbing crank drill”)
(“Antibody spikes on dino suit man”)
Calcitonin MOA
(“Curator toning it down”)
- released from the parafollicular cells of the thyroid
- Calcitonin inhibits osteoclasts
- decreased bone resorption
(“Curator grabbing classmate”)
-calcitonin promotes Ca2+ excretion by the kidney
(“Calci-Yum ice cream pouring down flank”)
Calcitonin clinical uses
-Used in the same clinical scenarios as
bisphosphonates but not 1st line [osteoporosis]
- hypercalcemia of malignancy is a common cause of sever hypercalcemia requiring acute treatment with bisphosphonates and calcitonin
(“Massive calcified rock with crab fossils”)
Calcitonin Side Effects
can cause hypocalcemia
(“Falling calci-yum ice cream”)